Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs ALEMBIC PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA ALEMBIC PHARMA AUROBINDO PHARMA/
ALEMBIC PHARMA
 
P/E (TTM) x 21.1 31.0 68.1% View Chart
P/BV x 2.2 4.3 51.4% View Chart
Dividend Yield % 0.3 0.8 35.4%  

Financials

 AUROBINDO PHARMA   ALEMBIC PHARMA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-23
ALEMBIC PHARMA
Mar-23
AUROBINDO PHARMA/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs715792 90.2%   
Low Rs397463 85.8%   
Sales per share (Unadj.) Rs424.2287.6 147.5%  
Earnings per share (Unadj.) Rs32.917.4 189.1%  
Cash flow per share (Unadj.) Rs54.131.4 172.4%  
Dividends per share (Unadj.) Rs3.008.00 37.5%  
Avg Dividend yield %0.51.3 42.3%  
Book value per share (Unadj.) Rs458.1222.3 206.0%  
Shares outstanding (eoy) m585.94196.56 298.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.32.2 60.0%   
Avg P/E ratio x16.936.1 46.8%  
P/CF ratio (eoy) x10.320.0 51.4%  
Price / Book Value ratio x1.22.8 43.0%  
Dividend payout %9.146.0 19.8%   
Avg Mkt Cap Rs m325,753123,402 264.0%   
No. of employees `000NANA-   
Total wages/salary Rs m35,22311,691 301.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m248,55456,526 439.7%  
Other income Rs m2,90630 9,558.9%   
Total revenues Rs m251,46056,557 444.6%   
Gross profit Rs m37,0706,772 547.4%  
Depreciation Rs m12,4462,754 451.9%   
Interest Rs m1,405502 280.0%   
Profit before tax Rs m26,1253,546 736.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,849126 5,431.0%   
Profit after tax Rs m19,2773,420 563.7%  
Gross profit margin %14.912.0 124.5%  
Effective tax rate %26.23.6 737.2%   
Net profit margin %7.86.1 128.2%  
BALANCE SHEET DATA
Current assets Rs m214,59929,139 736.5%   
Current liabilities Rs m114,93816,408 700.5%   
Net working cap to sales %40.122.5 178.0%  
Current ratio x1.91.8 105.1%  
Inventory Days Days2110 212.8%  
Debtors Days Days667 970.7%  
Net fixed assets Rs m176,66831,498 560.9%   
Share capital Rs m586393 149.0%   
"Free" reserves Rs m267,81343,312 618.3%   
Net worth Rs m268,39943,705 614.1%   
Long term debt Rs m6,1900-   
Total assets Rs m392,12560,637 646.7%  
Interest coverage x19.68.1 242.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.9 68.0%   
Return on assets %5.36.5 81.6%  
Return on equity %7.27.8 91.8%  
Return on capital %10.09.3 108.3%  
Exports to sales %33.746.4 72.6%   
Imports to sales %15.312.1 126.4%   
Exports (fob) Rs m83,70326,210 319.4%   
Imports (cif) Rs m38,0606,846 556.0%   
Fx inflow Rs m85,48326,210 326.1%   
Fx outflow Rs m41,4476,846 605.5%   
Net fx Rs m44,03619,364 227.4%   
CASH FLOW
From Operations Rs m23,8687,240 329.7%  
From Investments Rs m-39,778-4,476 888.7%  
From Financial Activity Rs m18,144-2,620 -692.6%  
Net Cashflow Rs m2,298144 1,596.7%  

Share Holding

Indian Promoters % 48.8 69.1 70.6%  
Foreign collaborators % 3.1 0.5 602.0%  
Indian inst/Mut Fund % 41.3 19.0 217.2%  
FIIs % 20.7 4.5 458.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 30.4 158.5%  
Shareholders   241,944 85,212 283.9%  
Pledged promoter(s) holding % 20.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Aurobindo Pharma vs ALEMBIC PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs ALEMBIC PHARMA Share Price Performance

Period Aurobindo Pharma ALEMBIC PHARMA S&P BSE HEALTHCARE
1-Day -1.56% -1.91% -0.95%
1-Month -3.74% -5.91% -5.01%
1-Year 111.19% 97.32% 57.49%
3-Year CAGR 6.75% 2.16% 18.15%
5-Year CAGR 5.19% 11.85% 18.88%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the ALEMBIC PHARMA share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of ALEMBIC PHARMA the stake stands at 69.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of ALEMBIC PHARMA.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 9.1%.

ALEMBIC PHARMA paid Rs 8.0, and its dividend payout ratio stood at 46.0%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of ALEMBIC PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.